Literature DB >> 18949622

Efficacy of rituximab in combination with steroids in refractory chronic lymphocytic leukemia.

J P Quinn, S Mohamedbhai, K Chipperfield, M Treacy, S D'Sa, A C Nathwani.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18949622     DOI： 10.1080/10428190802340192

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  4 in total

1.  Current and emerging treatments for chronic lymphocytic leukaemia.

Authors:  Tadeusz Robak; Krzysztof Jamroziak; Pawel Robak
Journal:  Drugs       Date:  2009       Impact factor: 9.546

2.  The spectrum of use of rituximab in chronic lymphocytic leukemia.

Authors:  Alessandra Tedeschi; Eleonora Vismara; Francesca Ricci; Enrica Morra; Marco Montillo
Journal:  Onco Targets Ther       Date:  2010-11-26       Impact factor: 4.147

3.  Five years of experience with rituximab plus high-dose dexamethasone for relapsed/refractory chronic lymphocytic leukemia.

Authors:  Martin Šimkovič; Monika Motyčková; David Belada; Pavel Vodárek; Rahul Kapoor; Hamna Jaffar; Filip Vrbacký; Pavel Žák; Lukáš Smolej
Journal:  Arch Med Sci       Date:  2015-12-08       Impact factor: 3.318

4.  Practical approach to management of chronic lymphocytic leukemia.

Authors:  Lukáš Smolej; Martin Šimkovič
Journal:  Arch Med Sci       Date:  2015-12-08       Impact factor: 3.318
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.